Renal system recommendations
On this page you will find our recommendations sorted by BNF chapter.Appraisal Reports are available to stakeholders on request.
Where a decision is >24 months old; these are highlighted in red. If you are a clinician working within the NTAG region and would like to prioritise an old decision for re-review please contact the professional secretary on firstname.lastname@example.org
|Top Tips and Recommendations for Dapagliflozin [FORXIGA] in Chronic Kidney Disease (CKD)||Dapagliflozin in CKD Top Tips NTAG v1 - approved June 2022||Approved by NTAG||07/06/2022|
|SGLT2-inhibitors and Chronic Kidney Disease - Patient Information Leaflet||SGLT2 CKD PIL NTAG v1||Approved by NTAG||07/06/2022|